An Interest In:
Web News this Week
- March 29, 2024
- March 28, 2024
- March 27, 2024
- March 26, 2024
- March 25, 2024
- March 24, 2024
- March 23, 2024
Some of Our Sources
- Technology Review
- Smashing Magazine
- Smashing Apps
- Abduzeedo
- Inspiredology
- Naldz Graphics
- Crazy Leaf Design
- 24 Ways
- CSS Tricks
- TechPowerUp
Help Webnuz
Referal links:
April 28, 2016 02:14 pm GMT
Drug research giant AbbVie announced a deal to buy cancer drug startup Stemcentrx in a $5.8 billion cash and stock deal this morning. The terms of the deal include $2 billion in cash and $3.8 billion in stock upfront, plus another $4 billion in milestone-based payouts to StemCentrx, and $3.8 in stock. The deal values the company at up to $10.2 billion, according to a memo from… Read More
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/ESNqE9PA_gY/
AbbVie acquiring cancer drug startup StemcenTrx for $5.8 billion
Drug research giant AbbVie announced a deal to buy cancer drug startup Stemcentrx in a $5.8 billion cash and stock deal this morning. The terms of the deal include $2 billion in cash and $3.8 billion in stock upfront, plus another $4 billion in milestone-based payouts to StemCentrx, and $3.8 in stock. The deal values the company at up to $10.2 billion, according to a memo from… Read MoreOriginal Link: http://feedproxy.google.com/~r/Techcrunch/~3/ESNqE9PA_gY/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch